Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-06FDA Approved: DESOXIMETASONE — Original Application (Saptalis Pharmaceuticals, LLC.)
The FDA approved an original ANDA application from Saptalis Pharmaceuticals for a desoximetasone topical product, a generic corticosteroid f…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study [NA]
A completed clinical trial evaluating an influenza vaccine in people with atopic dermatitis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Promoting Tolerance to Peanut in High-Risk Children [Phase 2]
Phase 2 trial update on promoting tolerance to peanut in high-risk children; completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Vitamin D Supplementation in Childhood Atopic Dermatitis [NA]
A completed clinical trial from Massachusetts General Hospital studied vitamin D supplementation in children with atopic dermatitis.
-
FDA approval · 2016-12-14FDA Approved: EUCRISA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved EUCRISA (crisaborole) in its original NDA, establishing the topical PDE-4 inhibitor as a treatment for atopic dermatitis. The a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-12-13FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
The FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) from Royal Pharmaceuticals.
-
FDA approval · 2016-12-12FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic desoximetasone topical (original application) for relief of inflammatory and pruritic manifestat…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating the efficacy and safety of apremilast in adults with moderate to severe atopic dermatitis completed with results po…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Effect of OC000459 on Moderate to Severe Atopic Dermatitis [Phase 2]
This update reports the completion of a Phase 2 trial of OC000459 for moderate-to-severe atopic dermatitis and notes that results were poste…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients [Phase 2]
The Phase 2 safety and efficacy study of Q301 for moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Randomized Controlled Trial of an Eczema Care Plan [NA]
A randomized controlled trial evaluating an eczema care plan has completed. The update does not report trial results.
-
CLINICAL_TRIALS withdrawal · 2016-12-01Clinical Trial Update: A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM) [Phase 2]
Withdrawal notice for a Phase 2 placebo-controlled proof-of-concept study evaluating 0.5% roflumilast cream in mild atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion [Phase 4]
Open-label Phase 4 study assessing systemic exposure of pimecrolimus cream 1% under occlusion in adult and pediatric atopic dermatitis patie…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old [Phase 4]
A completed Phase 4 clinical trial assessing whether pimecrolimus improves pruritus in children aged 2 to 11 with mild-to-moderate atopic de…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema [NA]
A completed clinical trial evaluating the tolerance of a nighttime moisturizing balm for eczema in babies and adults, with results posted on…
-
FDA approval · 2016-11-07FDA Approved: DESOXIMETASONE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's generic desoximetasone under an original ANDA, enabling a new topical corticosteroid product to reach the mark…
-
FDA label_change · 2016-11-02FDA Approved: TRIDESILON CREAM — Supplemental Application (Encore Dermatology Inc)
FDA approved a supplemental application for Tridesilon Cream (desonide 0.05%), updating the product labeling.
-
FDA approval · 2016-10-26FDA Approved: TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA granted approval of a supplemental application for Triamcinolone Acetonide submitted by Sun Pharmaceutical Industries, Inc., resulting i…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Psychiatric Problems in Chronic Skin Diseases
A clinical trial examining psychiatric problems in chronic skin diseases has completed, with the study covering psoriasis, acne vulgaris, vi…
-
FDA approval · 2016-10-21FDA Approved: FLUOCINOLONE ACETONIDE TOPICAL — Original Application (Actavis Pharma, Inc.)
FDA approved a generic fluocinonide acetonide topical product under an original application from Actavis Pharma, Inc.
-
CLINICAL_TRIALS research · 2016-10-18Clinical Trial Update: Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus
A clinical trial update from NIAID explores the role of antimicrobial peptides in host defense against vaccinia virus in individuals with At…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD) [Phase 1, Phase 2]
Completed Phase 1/2 trial evaluating the safety and efficacy of FURESTEM-AD Inj. in patients with moderately subacute and chronic atopic der…
-
CLINICAL_TRIALS research · 2016-10-06Clinical Trial Update: Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis
A completed clinical trial evaluating risk factors for eczema herpeticum in individuals with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis [Phase 4]
This Phase 4 trial evaluates efficacy and tolerability of new topical formulations for atopic dermatitis. The study, sponsored by Procter & …
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects [Phase 1]
Phase 1 trial evaluating safety and pharmacokinetics of OPA-15406 ointment in healthy adult male volunteers for potential use in Atopic Derm…